Antiparkinsonian Actions of Ifenprodil in the MPTP-Lesioned Marmoset Model of Parkinson's Disease
Authors:
- S.H. FoxSFS.H. Fox
- J.M. BrotchieJ.M. Brotchie
- 1 September 2000
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 165 (1) , 136-142
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Novel approaches to the symptomatic treatment of parkinsonian syndromesCurrent Opinion in Neurology, 1997
- Chapter 8 Chemical signalling in the globus pallidus in parkinsonism1993
- [3H]MK‐801 Binding to N‐Methyl‐d‐Aspartate Receptors Solubilized from Rat Brain: Effects of Glycine Site Ligands, Polyamines, Ifenprodil, and DesipramineJournal of Neurochemistry, 1991
- The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's diseaseJournal of the Neurological Sciences, 1990
- Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systemsPharmacology Biochemistry and Behavior, 1990
- The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted miceLife Sciences, 1990
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted miceJournal of Neural Transmission, 1989
- Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted miceJournal of Neural Transmission, 1989
- Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)—induced parkinsonism in the macaque monkeyNeuropharmacology, 1985
- Parkinson Disease Treated With a Suspected Dopamine Receptor AgonistArchives of Neurology, 1974